%0 Journal Article
%T AD-MSCs and BM-MSCs Ameliorating Effects on The Metabolic and Hepato-renal Abnormalities in Type 1 Diabetic Rats.
%A El-Sawah SG
%A Rashwan HM
%A Althobaiti F
%A Aldhahrani A
%A Fayad E
%A Shabana ES
%A El-Hallous EI
%A Amen RM
%A El-Sawah SG
%A Rashwan HM
%A Althobaiti F
%A Aldhahrani A
%A Fayad E
%A Shabana ES
%A El-Hallous EI
%A Amen RM
%J Saudi J Biol Sci
%V 29
%N 2
%D Feb 2022
%M 35197774
%F 4.052
%R 10.1016/j.sjbs.2021.09.067
%X Diabetes mellitus (DM) is one of the most serious threats in the 21th century throughout the human population that needs to be addressed cautiously. Nowadays, stem cell injection is considered among the most promising protocols for DM therapy; owing to its marked tissues and organs repair capability. Therefore, our 4 weeks study was undertaken to elucidate the probable beneficial effects of two types of adult mesenchymal stem cells (MSCs) on metabolism disturbance and some tissue function defects in diabetic rats. Animals were classified into 4 groups; the control group, the diabetic group, the diabetic group received a single dose of adipose tissue-derived MSCs and the diabetic group received a single dose of bone marrow-derived MSCs. Herein, both MSCs treated groups markedly reduced hyperglycemia resulting from diabetes induction via lowering serum glucose and rising insulin and C-peptide levels, compared to the diabetic group. Moreover, the increased lipid fractions levels were reverted back to near normal values as a consequence to MSCs injection compared to the diabetic untreated rats. Furthermore, both MSCs types were found to have hepato-renal protective effects indicated through the decreased serum levels of both liver and kidney functions markers in the treated diabetic rats. Taken together, our results highlighted the therapeutic benefits of both MSCs types in alleviating metabolic anomalies and hepato-renal diabetic complications.